Skip to main content

MedCloud Minute

Blog archive

Pictor Introduces Automated Protein Analysis System at ADLM 2026

Key Takeaways

  • Pictor launches the Pictimager to automate targeted protein analysis for clinical laboratories and biomedical research.
  • Pictimager streamlines biomarker research with automated imaging, protein assays and enhanced laboratory workflow efficiency.
  • Automated targeted proteomics platform supports oncology, immune profiling, translational research and clinical diagnostics.

Pictor, a global targeted proteomic platform company, has introduced the Pictimager, a new instrument designed to make targeted protein analysis more accessible for clinical laboratories and biomedical researchers by automating key steps in the testing process.

The company unveiled the platform at the Association for Diagnostics & Laboratory Medicine (ADLM) 2026 conference, saying the system combines automated imaging and analysis to help laboratories perform targeted protein assays with less manual effort. The instrument is intended to improve workflow efficiency while supporting applications in biomarker research, translational medicine and clinical diagnostics.

The instrument incorporates an enhanced design for improved usability and imaging capability, and a more robust architecture intended to support beta-site evaluation and broader commercial deployment. The integrated platform is designed to support research applications including biomarker research, translational research, immune profiling, oncology research, vaccine response, and longitudinal biomarker monitoring.

The platform is designed for laboratories seeking to expand protein analysis capabilities without the complexity associated with traditional high-end research instruments. By automating imaging and analytical workflows, Pictor aims to reduce hands-on time while improving consistency across experiments.

Posted by MedCloudInsider Editors on 07/28/2026